Bitech Technologies Signs Letter of Intent with Value Added Reseller Paladin Power

2 years ago

Costa Mesa, CA, June 22, 2022 (GLOBE NEWSWIRE) -- Bitech Technologies Corporation (formerly, Spine Injury Solutions, Inc) [OTCQB: SPIN] (the…

Nanomix Initiates New Clinical Study for the eLab S1 Panel

2 years ago

Study incorporates the use of the Nanomix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in…

ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products

2 years ago

The Company’s improved, new Vitastem products have recently begun large scale productionLOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma,…

Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference

2 years ago

SAN DIEGO, June 22, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics,…

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting

2 years ago

Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® PlatformEMERYVILLE, Calif., June…

Healthy Extracts’ WHITNEY JOHNS ACTIVE™ Clinically Proven to Enhance Physical Performance by Increasing Nitric Oxide by 73% and Oxygen Consumption by 24%

2 years ago

Image 1 Whitney Johns ACTIVELAS VEGAS, June 22, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator…

CytoDyn to Hold Webcast to Provide a Quarterly Company Update

2 years ago

VANCOUVER, Washington, June 22, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company…

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation

2 years ago

Company to discuss positive topline and additional clinical data for CY6463 in MELAS patients Mitochondrial disease clinician-researcher, Amel Karaa, M.D.,…

Biomea Fusion Announces First Patient Dosed in Multiple Myeloma Cohort of COVALENT-101 Trial

2 years ago

BMF-219, a covalent menin inhibitor, is the first menin inhibitor administered to patients with relapsed/refractory (R/R) multiple myeloma (MM)Patients with…

Athenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree

2 years ago

Company executes on strategy to extend cash runway by monetizing non-core assetsTotal transaction value of $85 million; at least $80…